Testing effectiveness (Phase 2)Study completedNCT02511132
What this trial is testing
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma
Who this might be right for
Ewing's Sarcoma
Gradalis, Inc. 22